Focused screening of a panel of cancer‐related genetic polymorphisms reveals new susceptibility loci for pediatric acute lymphoblastic leukemia
dc.contributor.author | Offenmüller, Sonja | en_US |
dc.contributor.author | Ravindranath, Yadddanapudi | en_US |
dc.contributor.author | Goyette, Gerard | en_US |
dc.contributor.author | Kanakapalli, Deepa | en_US |
dc.contributor.author | Miller, Kathryn S. | en_US |
dc.contributor.author | Brecht, Ines B. | en_US |
dc.contributor.author | Zolk, Oliver | en_US |
dc.date.accessioned | 2014-07-03T14:41:24Z | |
dc.date.available | WITHHELD_14_MONTHS | en_US |
dc.date.available | 2014-07-03T14:41:24Z | |
dc.date.issued | 2014-08 | en_US |
dc.identifier.citation | Offenmüller, Sonja ; Ravindranath, Yadddanapudi; Goyette, Gerard; Kanakapalli, Deepa; Miller, Kathryn S.; Brecht, Ines B.; Zolk, Oliver (2014). "Focused screening of a panel of cancerâ related genetic polymorphisms reveals new susceptibility loci for pediatric acute lymphoblastic leukemia." Pediatric Blood & Cancer 61(8): 1411-1415. | en_US |
dc.identifier.issn | 1545-5009 | en_US |
dc.identifier.issn | 1545-5017 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/107514 | |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Candidate Gene Association Study | en_US |
dc.subject.other | Childhood Acute Lymphoblastic Leukemia | en_US |
dc.subject.other | ERCC2 | en_US |
dc.subject.other | MSR1 | en_US |
dc.subject.other | PPP1R13L | en_US |
dc.title | Focused screening of a panel of cancer‐related genetic polymorphisms reveals new susceptibility loci for pediatric acute lymphoblastic leukemia | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pediatrics | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/107514/1/pbc25011-sm-0001-SuppData-S1.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/107514/2/pbc25011.pdf | |
dc.identifier.doi | 10.1002/pbc.25011 | en_US |
dc.identifier.source | Pediatric Blood & Cancer | en_US |
dc.identifier.citedreference | Hernandez‐Boluda JC, Pereira A, Cervantes F, et al. A polymorphism in the XPD gene predisposes to leukemic transformation and new nonmyeloid malignancies in essential thrombocythemia and polycythemia vera. Blood 2012; 119: 5221 – 5228. | en_US |
dc.identifier.citedreference | Chen J, Pande M, Huang YJ, et al. Cell cycle‐related genes as modifiers of age of onset of colorectal cancer in Lynch syndrome: A large‐scale study in non‐Hispanic white patients. Carcinogenesis 2013; 34: 299 – 306. | en_US |
dc.identifier.citedreference | Barwick BG, Abramovitz M, Kodani M, et al. Prostate cancer genes associated with TMPRSS2‐ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts. Br J Cancer 2010; 102: 570 – 576. | en_US |
dc.identifier.citedreference | Gillotin S, iASPP, a potential drug target in cancer therapy. Leukemia Res 2009; 33: 1175 – 1177. | en_US |
dc.identifier.citedreference | Laska MJ, Vogel UB, Jensen UB, et al. p53 and PPP1R13L (alias iASPP or RAI) form a feedback loop to regulate genotoxic stress responses. Biochim Biophys Acta 2010; 1800: 1231 – 1240. | en_US |
dc.identifier.citedreference | Yin J, Guo L, Wang C, et al. Effects of PPP1R13L and CD3EAP variants on lung cancer susceptibility among nonsmoking Chinese women. Gene 2013; 524: 228 – 231. | en_US |
dc.identifier.citedreference | Pinto EM, Musolino NR, Cescato VA, et al. iASPP: A novel protein involved in pituitary tumorigenesis ? Front Horm Res 2010; 38: 70 – 76. | en_US |
dc.identifier.citedreference | Zhang X, Wang M, Zhou C, et al. The expression of iASPP in acute leukemias. Leukemia Res 2005; 29: 179 – 183. | en_US |
dc.identifier.citedreference | Wang F, Chang D, Hu FL, et al. DNA repair gene XPD polymorphisms and cancer risk: A meta‐analysis based on 56 case‐control studies. Cancer Epidemiol Biomarkers Prev 2008; 17: 507 – 517. | en_US |
dc.identifier.citedreference | Popp HD, Bohlander SK. Genetic instability in inherited and sporadic leukemias. Genes Chromosome Cancer 2010; 49: 1071 – 1081. | en_US |
dc.identifier.citedreference | Allan JM, Smith AG, Wheatley K, et al. Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. Blood 2004; 104: 3872 – 3877. | en_US |
dc.identifier.citedreference | Susini MC, Guglielmelli P, Spolverini A, et al. The ERCC2 Gln/Gln polymorphism at codon 751 is not associated with leukaemic transformation in primary myelofibrosis. Br J Haematol 2013; 162: 424 – 427. | en_US |
dc.identifier.citedreference | Poletto V, Villani L, Catarsi P, et al. No association between the XPD Lys751Gln (rs13181) polymorphism and disease phenotype or leukemic transformation in primary myelofibrosis. Haematologica 2013; 98: e83 – 84. | en_US |
dc.identifier.citedreference | Ganster C, Neesen J, Zehetmayer S, et al. DNA repair polymorphisms associated with cytogenetic subgroups in B‐cell chronic lymphocytic leukemia. Genes Chromosome Cancer 2009; 48: 760 – 767. | en_US |
dc.identifier.citedreference | Chokkalingam AP, Bartley K, Wiemels JL, et al. Haplotypes of DNA repair and cell cycle control genes, X‐ray exposure, and risk of childhood acute lymphoblastic leukemia. Cancer Cause Control 2011; 22: 1721 – 1730. | en_US |
dc.identifier.citedreference | Batar B, Guven M, Baris S, et al. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia. Leukemia Res 2009; 33: 759 – 763. | en_US |
dc.identifier.citedreference | Pakakasama S, Sirirat T, Kanchanachumpol S, et al. Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2007; 48: 16 – 20. | en_US |
dc.identifier.citedreference | Alvarez‐Cubero MJ, Saiz M, Martinez‐Gonzalez LJ, et al. Genetic analysis of the principal genes related to prostate cancer: A review. Urol Oncol 2013; 31: 1419 – 1429. | en_US |
dc.identifier.citedreference | Sun J, Hsu FC, Turner AR, et al. Meta‐analysis of association of rare mutations and common sequence variants in the MSR1 gene and prostate cancer risk. Prostate 2006; 66: 728 – 737. | en_US |
dc.identifier.citedreference | Chen Y, Sullivan C, Peng C, et al. A tumor suppressor function of the Msr1 gene in leukemia stem cells of chronic myeloid leukemia. Blood 2011; 118: 390 – 400. | en_US |
dc.identifier.citedreference | Xu H, Yang W, Perez‐Andreu V, et al. Novel susceptibility variants at 10p12.31–12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Canc Inst 2013; 105: 733 – 742. | en_US |
dc.identifier.citedreference | Seimon TA, Obstfeld A, Moore KJ, et al. Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages. Proc Natl Acad Sci U S A 2006; 103: 19794 – 19799. | en_US |
dc.identifier.citedreference | Tanaka T, Akira S, Yoshida K, et al. Targeted disruption of the NF‐IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 1995; 80: 353 – 361. | en_US |
dc.identifier.citedreference | Schmidt L, Duh FM, Chen F, et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto‐oncogene in papillary renal carcinomas. Nat Genet 1997; 16: 68 – 73. | en_US |
dc.identifier.citedreference | Schutz FA, Pomerantz MM, Gray KP, et al. Single nucleotide polymorphisms and risk of recurrence of renal‐cell carcinoma: A cohort study. Lancet Oncol 2013; 14: 81 – 87. | en_US |
dc.identifier.citedreference | Pui CH, Carroll WL, Meshinchi S, et al. Biology, risk stratification, and therapy of pediatric acute leukemias: An update. J Clin Oncol 2011; 29: 551 – 565. | en_US |
dc.identifier.citedreference | Mullighan CG. Molecular genetics of B‐precursor acute lymphoblastic leukemia. J Clin Invest 2012; 122: 3407 – 3415. | en_US |
dc.identifier.citedreference | Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 2009; 41: 1006 – 1010. | en_US |
dc.identifier.citedreference | Trevino LR, Yang W, French D, et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 2009; 41: 1001 – 1005. | en_US |
dc.identifier.citedreference | Han S, Lee KM, Park SK, et al. Genome‐wide association study of childhood acute lymphoblastic leukemia in Korea. Leukemia Res 2010; 34: 1271 – 1274. | en_US |
dc.identifier.citedreference | Sherborne AL, Hosking FJ, Prasad RB, et al. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet 2010; 42: 492 – 494. | en_US |
dc.identifier.citedreference | Ellinghaus E, Stanulla M, Richter G, et al. Identification of germline susceptibility loci in ETV6‐RUNX1‐rearranged childhood acute lymphoblastic leukemia. Leukemia 2012; 26: 902 – 909. | en_US |
dc.identifier.citedreference | Enciso‐Mora V, Hosking FJ, Sheridan E, et al. Common genetic variation contributes significantly to the risk of childhood B‐cell precursor acute lymphoblastic leukemia. Leukemia 2012; 26: 2212 – 2215. | en_US |
dc.identifier.citedreference | Wesolowska A, Dalgaard MD, Borst L, et al. Cost‐effective multiplexing before capture allows screening of 25,000 clinically relevant SNPs in childhood acute lymphoblastic leukemia. Leukemia 2011; 25: 1001 – 1006. | en_US |
dc.identifier.citedreference | Packer BR, Yeager M, Burdett L, et al. SNP500Cancer: A public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucl Acid Res 2006; 34: D617 – D621. | en_US |
dc.identifier.citedreference | Vijayakrishnan J, Houlston RS. Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta‐analysis. Haematologica 2010; 95: 1405 – 1414. | en_US |
dc.identifier.citedreference | Trenk D, Hochholzer W, Fromm MF, et al. Paraoxonase‐1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placement. Circ Cardiovasc Genet 2011; 4: 429 – 436. | en_US |
dc.identifier.citedreference | Purcell S, Neale B, Todd‐Brown K, et al. PLINK: A tool set for whole‐genome association and population‐based linkage analyses. Am J Hum Genet 2007; 81: 559 – 575. | en_US |
dc.identifier.citedreference | Dupont WD, Plummer WD, Jr. Power and sample size calculations. A review and computer program. Controlled Clin Trials 1990; 11: 116 – 128. | en_US |
dc.identifier.citedreference | Wang L, Yin F, Xu X, et al. X‐ray repair cross‐complementing group 1 (XRCC1) genetic polymorphisms and risk of childhood acute lymphoblastic leukemia: A meta‐analysis. PLoS ONE 2012; 7: e34897. | en_US |
dc.identifier.citedreference | Urayama KY, Chokkalingam AP, Manabe A, et al. Current evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia. Int J Hematol 2013; 97: 3 – 19. | en_US |
dc.identifier.citedreference | Wang H, Wang J, Zhao L, et al. Methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia‐evidence from an updated meta‐analysis including 35 studies. BMC Med Genet 2012; 13: 77. | en_US |
dc.identifier.citedreference | de Jonge R, Tissing WJ, Hooijberg JH, et al. Polymorphisms in folate‐related genes and risk of pediatric acute lymphoblastic leukemia. Blood 2009; 113: 2284 – 2289. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.